Suyu Shu

4.7k citations
95 papers · 3.8k indexed · 1 hit paper · h-index 36

Suyu Shu

95 papers receiving 3.6k citations

Hit Papers

Adoptive Immunotherapy of Established Pulmonary Metastase...5601984202619982012100200300400500

Peers

Suyu Shu
Comparison fields: 5 of 101
  • Immunology 3.0k
  • Oncology 2.0k
  • Biotechnology 194
  • Genetics 413
  • Molecular Biology 800
Replace Deborah R. Surman with:
Deborah R. Surman United States
Laura Bover United States
Glen Dranoff United States
Erik Hooijberg Netherlands
Alexander L. Rakhmilevich United States
Cynthia A. Chambers United States
Hirokazu Matsushita Japan
S Shu United States
Andrew Kaiser Germany
Ainhoa Arina United States
Suyu Shu relative to Deborah R. Surman United States Deborah R. Surman's profile →
Citations per field
00.5×1.6×
Deborah R. Surman · 1×
Citations per year

Countries citing papers authored by Suyu Shu

Since Specialization
Citations

This map shows the geographic impact of Suyu Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suyu Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suyu Shu more than expected).

Fields of papers citing papers by Suyu Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suyu Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suyu Shu. The network helps show where Suyu Shu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Suyu Shu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Suyu Shu Line = papers co-authored together Suyu Shu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201018
2 2008111
3 20084
4 200793
5 200620
6 200424
7 200463
8 200385
9 200161
10 200027
11 200039
12 199811
13 19971
14 19971
15 19963
16 199416
17 19934
18 199344
19 199222
20 19923

About Suyu Shu

Suyu Shu is a scholar working on Immunology, Oncology and Biotechnology, having authored 95 papers that have together received 3.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (82 papers), CAR-T cell therapy research (47 papers), Immune Cell Function and Interaction (28 papers), T-cell and B-cell Immunology (19 papers), Cancer Immunotherapy and Biomarkers (14 papers), Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Immunology (3.0k citations), Oncology (2.0k citations) and Biotechnology (194 citations). Suyu Shu has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Steven A. Rosenberg, Jørgen Kjaergäard, Gregory E. Plautz, James J. Mulé, Susan Schwarz, Peter A. Cohen, Alfred E. Chang, Junta Tanaka, Hiroshi Tanaka and Liaomin Peng. Their work appears in journals such as The Journal of Immunology, Journal of Immunotherapy, Cellular Immunology, Clinical Immunology and Critical Reviews in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026